Toshimichi Yoshida Selected Research

Synovitis

12/2021	TNIIIA2, The Peptide of Tenascin-C, as a Candidate for Preventing Articular Cartilage Degeneration.
1/2020	Tenascin-C in Osteoarthritis and Rheumatoid Arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshimichi Yoshida Research Topics

Disease

21	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022 - 05/2008
14	Inflammation (Inflammations) 11/2020 - 09/2002
12	Intracranial Vasospasm 01/2020 - 03/2010
11	Neoplasms (Cancer) 10/2020 - 04/2002
9	Brain Injuries (Brain Injury) 01/2022 - 04/2014
8	Osteoarthritis 12/2021 - 01/2008
8	Myocardial Infarction 01/2021 - 06/2006
6	Fibrosis (Cirrhosis) 11/2020 - 04/2006
6	Hyperplasia 02/2015 - 09/2004
6	Myocarditis (Carditis) 11/2014 - 07/2002
6	Neointima 10/2011 - 01/2003
5	Heart Diseases (Heart Disease) 11/2020 - 07/2009
5	Breast Neoplasms (Breast Cancer) 10/2020 - 05/2003
5	Brain Edema (Cerebral Edema) 01/2020 - 01/2016
5	Aneurysm (Aneurysms) 04/2016 - 01/2003
4	Rheumatoid Arthritis 01/2020 - 05/2007
3	Ischemia 01/2015 - 07/2010
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015 - 07/2010
3	Body Weight (Weight, Body) 01/2015 - 04/2012
3	Ventricular Remodeling 01/2015 - 06/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 06/2006
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2009 - 03/2007
3	Thrombosis (Thrombus) 07/2006 - 01/2003
2	Synovitis 12/2021 - 01/2020
2	Wounds and Injuries (Trauma) 07/2020 - 02/2015
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2020 - 10/2005
2	Neuroinflammatory Diseases 01/2020 - 11/2018
2	Herpes Zoster 01/2017 - 06/2016
2	Aortic Dissection 07/2015 - 10/2013
2	Knee Osteoarthritis 01/2011 - 10/2004
2	Heart Failure 12/2009 - 03/2007
2	Pathologic Constriction (Stenosis) 06/2007 - 01/2003
2	Chronic Hepatitis C 04/2007 - 04/2006
2	Aortic Aneurysm (Aneurysm, Aortic) 07/2006 - 08/2005
1	Jaundice (Icterus) 05/2023
1	Edema (Dropsy) 01/2020
1	Cerebral Infarction 01/2020
1	Rupture 01/2020
1	Joint Diseases (Joint Disease) 03/2018
1	Adenocarcinoma 01/2018

Drug/Important Bio-Agent (IBA)

69	TenascinIBA 05/2023 - 04/2002
15	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2005
9	Glycoproteins (Glycoprotein)IBA 10/2016 - 09/2002
6	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2011
6	Extracellular Matrix ProteinsIBA 01/2019 - 07/2002
5	OsteopontinIBA 01/2016 - 02/2009
4	IntegrinsIBA 10/2020 - 12/2011
4	Toll-Like Receptor 4IBA 01/2020 - 09/2007
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017 - 05/2003
4	Matrix Metalloproteinases (MMPs)IBA 06/2016 - 05/2003
4	Transforming Growth Factor beta (TGF-beta)IBA 04/2016 - 05/2003
4	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 04/2012
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2014 - 05/2007
4	Monoclonal AntibodiesIBA 07/2008 - 09/2002
3	CytokinesIBA 01/2021 - 11/2014
3	Mitogen-Activated Protein KinasesIBA 01/2020 - 04/2012
3	Cilostazol (Pletal)FDA LinkGeneric 01/2020 - 09/2004
3	Fibrinogen (Factor I)FDA Link 01/2020 - 06/2003
3	Phosphotransferases (Kinase)IBA 01/2017 - 04/2012
3	PlatinumIBA 04/2016 - 10/2005
3	InterleukinsIBA 11/2014 - 01/2005
2	Peptides (Polypeptides)IBA 01/2020 - 11/2014
2	LigandsIBA 01/2020 - 12/2011
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2018 - 01/2015
2	gellan sulfateIBA 04/2016 - 10/2014
2	Phenobarbital (Luminal)FDA Link 04/2016 - 01/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2005
2	Interleukin-1 (Interleukin 1)IBA 01/2014 - 01/2005
2	Angiotensin IIIBA 09/2013 - 05/2007
2	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 04/2012
2	Platelet-Derived Growth FactorIBA 01/2013 - 04/2012
2	Thrombin FDA Link 01/2011 - 02/2009
2	Immunoglobulin Fab FragmentsIBA 07/2008 - 09/2002
2	Poloxamer (Poloxamer 407)IBA 10/2007 - 09/2004
2	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 10/2007 - 09/2004
2	Adenosine Monophosphate (AMP)IBA 10/2007 - 09/2004
2	Myosins (Myosin)IBA 09/2007 - 07/2002
2	CollagenIBA 08/2005 - 01/2003
2	GelatinIBA 03/2005 - 05/2003
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2004 - 04/2002
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2004 - 05/2003
1	BilirubinIBA 05/2023
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2022
1	PropionatesIBA 01/2022
1	ChemokinesIBA 01/2021
1	CalponinsIBA 10/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2020
1	Protective AgentsIBA 07/2020
1	rebamipideIBA 07/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Heme (Haem)IBA 01/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020

Therapy/Procedure

4	Therapeutics 11/2020 - 01/2005
3	Intra-Articular Injections 12/2021 - 01/2018
3	Stents 02/2015 - 01/2003
2	Endovascular Aneurysm Repair 07/2006 - 08/2005
2	Cell Transplantation 07/2006 - 08/2005
1	Liver Transplantation 05/2023
1	Molecular Targeted Therapy 11/2018
1	Chemoradiotherapy 01/2018